Poor
Poorly Aligned
Patient Risk:
Low
Summary
All extracted dosing/administration claims are not supported by the provided label sections (2.2, 2.11). The label provides general subcutaneous administration guidance and device options but does not explicitly authorize single-dose per-injection usage, prohibit pooling, or give discarding/improvisation guidance described in the claims.
Category Scores
Accurate Statements
Unsupported Statements
Cosentyx (secukinumab) is intended to be injected as separate, single-dose administrations.
Not supported by label (absent from label).
You should not pool doses or use one syringe to give multiple “shots.”
Not supported by label (absent from label).
Each planned injection dose requires its own prefilled syringe or pen, prepared and used according to the product instructions.
Not supported by label (absent from label).
Using a single syringe for more than one dose can lead to incorrect dosing (you may under-dose some injections or contaminate the remaining medication).
Not supported by label (absent from label).
You may under-dose some injections.
Not supported by label (absent from label).
You may contaminate the remaining medication.
Not supported by label (absent from label).
The syringe is not designed to be reused after the first injection attempt.
Not supported by label (absent from label).
If your prescribed regimen requires multiple injections in the same dosing day, you generally use the required number of separate prefilled syringes or pens, one per injection site, rather than trying to combine doses into fewer syringes.
Not supported by label (absent from label).
You should not try to combine doses into fewer syringes.
Not supported by label (absent from label).
If you already tried to use one syringe for multiple shots or you’re not sure what you have left, do not try to improvise.
Not supported by label (absent from label).
Contact your prescribing clinician or pharmacist for specific guidance on whether any remaining medication should be discarded and how to proceed with the next dose.
Not supported by label (absent from label).
If contamination or incorrect dosing is a concern, you may also worry about injection-site reactions and general medication safety.
Not supported by label (absent from label).
Your clinician can sometimes adjust your regimen or help you choose the most practical Cosentyx device (prefilled syringe vs. pen) for your prescribed number of injections per dose day.
Not supported by label (absent from label).
The key is that each injection still should use the correct single-dose device.
Not supported by label (absent from label).
Contradictions
Important Omissions
Label does not explicitly address pooling of doses, reuse of syringes, discarding remaining medication, improvisation guidance, or per-dose device selection for multiple injections per day. In addition, it does not state that each dose must be administered with a separate single-dose device in the per-dose day context.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
Evaluation focused on alignment with label; no new safety risks identified beyond the absence of explicit label guidance for described practices.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Poorly Aligned
Primary Issue
Claims about dosing administration, pooling, single-syringe usage, and device selection are not supported by the label.
Suggested Improvement
Align claims with label text (sections 2.2 and 2.11): emphasize subcutaneous administration, use of UniReady/SenseoReady/pre-filled syringes, and per-injection site guidance; remove or rephrase statements about pooling doses, syringe reuse, discarding remaining medication, improvisation, and clinician-directed regimen adjustments unless explicitly stated in the label.